Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials
Cardiovascular Drugs and Therapy · 2025-04 · 39 (2) · 337-345
DOI: 10.1007/s10557-024-07547-3 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 12.01.2024. Verfasst von Daniel A Gomes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Av. Prof. Dr. Reinaldo Dos Santos, Carnaxide, 2790-134, Lisbon,…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Weight Loss, Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Department, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Av. Prof. Dr. Reinaldo Dos Santos, Carnaxide, 2790-134, Lisbon, Portugal. danielssagomes@gmail.com.
- Cardiology Department, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Av. Prof. Dr. Reinaldo Dos Santos, Carnaxide, 2790-134, Lisbon, Portugal.
- Comprehensive Health Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.
ORCID-Profile: Daniel A Gomes
Zitieren
APA
Gomes, D. A., Presume, J., de Araújo Gonçalves, P., Almeida, M. S., Mendes, M., & Ferreira, J. (2025). Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials. Cardiovascular Drugs and Therapy, 39(2), 337-345. https://doi.org/10.1007/s10557-024-07547-3
Vancouver
Gomes DA, Presume J, de Araújo Gonçalves P, Almeida MS, Mendes M, Ferreira J. Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials. Cardiovascular Drugs and Therapy. 2025;39(2):337-345. doi:10.1007/s10557-024-07547-3
BibTeX
@article{Gomes2025,
author = {Gomes, Daniel A and Presume, João and de Araújo Gonçalves, Pedro and Almeida, Manuel Sousa and Mendes, Miguel and Ferreira, Jorge},
title = {Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials},
journal = {Cardiovascular Drugs and Therapy},
year = {2025},
volume = {39},
number = {2},
pages = {337--345},
doi = {10.1007/s10557-024-07547-3}
}
EUVIMED